<description>&lt;p&gt;Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD.&lt;br /&gt; &lt;br /&gt; &lt;strong&gt;Related Content:&lt;/strong&gt;&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a class="related-article" href= "https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2025.5098?utm_source=podcast_platforms&amp;utm_medium=referral&amp;utm_campaign=related_article_links" target="_blank" rel="noopener"&gt;Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

JAMA Ophthalmology Author Interviews

JAMA Network

Aflibercept Dose in Polypoidal Choroidal Vasculopathy

DEC 18, 202516 MIN
JAMA Ophthalmology Author Interviews

Aflibercept Dose in Polypoidal Choroidal Vasculopathy

DEC 18, 202516 MIN

Description

Interview with Tien Y. Wong, MD, PhD, author of Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial. Hosted by Neil Bressler, MD. Related Content: Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy